HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Relapsed stage I neuroblastoma successfully treated by allogeneic bone marrow transplantation in second remission: case report of a 7-year-old girl].

Abstract
Stage I neuroblastoma in a seven-year-girl have had local recurrence with bone metastasis. Second surgery was performed after the aggressive chemotherapy including cisplatin, VP16, cyclophosphamide, vincristine and doxorubicin. She underwent allogeneic bone marrow transplantation from her HLA identical brother, following the preparative regimen consisting of high-dose melphalan and total body irradiation (12 Gy). Clinical course after the transplantation was uneventful. She is still alive with no evidence of disease for twenty-eight months after the transplantation. It is suggested that bone marrow transplantation is an effective way of therapy even in a patient with relapsed neuroblastoma.
AuthorsR Hanada, A Yaginuma, Y Hayashi, T Inaba, K Yamamoto, S Imaizumi, A Hirata, T Sugawara, T Aihara, T Miyakawa
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 17 Issue 9 Pg. 1937-9 (Sep 1990) ISSN: 0385-0684 [Print] Japan
PMID2203317 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Melphalan
Topics
  • Adrenal Gland Neoplasms (pathology)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bone Marrow Transplantation
  • Bone Neoplasms (drug therapy, secondary, surgery)
  • Child
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Etoposide (administration & dosage)
  • Female
  • Humans
  • Melphalan (administration & dosage)
  • Neuroblastoma (drug therapy, secondary, surgery)
  • Remission Induction
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: